{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T12:01:39Z","timestamp":1776772899336,"version":"3.51.2"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T00:00:00Z","timestamp":1663027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T00:00:00Z","timestamp":1663027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"JSPS KAKENHI","award":["16K08973"],"award-info":[{"award-number":["16K08973"]}]},{"name":"JSPS KAKENHI","award":["19K08478"],"award-info":[{"award-number":["19K08478"]}]},{"name":"Kitasato University Research Grant for Young Researchers","award":["2013"],"award-info":[{"award-number":["2013"]}]},{"name":"Kitasato University Research Grant for Young Researchers","award":["2014"],"award-info":[{"award-number":["2014"]}]},{"name":"Kitasato University Research Grant for Young Researchers","award":["2015"],"award-info":[{"award-number":["2015"]}]},{"DOI":"10.13039\/501100020291","name":"Kitasato University School of Allied Health Sciences","doi-asserted-by":"crossref","award":["2017-1014"],"award-info":[{"award-number":["2017-1014"]}],"id":[{"id":"10.13039\/501100020291","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100020291","name":"Kitasato University School of Allied Health Sciences","doi-asserted-by":"crossref","award":["2018-1026"],"award-info":[{"award-number":["2018-1026"]}],"id":[{"id":"10.13039\/501100020291","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100020291","name":"Kitasato University School of Allied Health Sciences","doi-asserted-by":"crossref","award":["2019-1015"],"award-info":[{"award-number":["2019-1015"]}],"id":[{"id":"10.13039\/501100020291","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s00277-022-04973-x","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T15:11:57Z","timestamp":1663081917000},"page":"2433-2444","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["B cell-activating factor is involved in thrombocytopenia in patients with liver cirrhosis"],"prefix":"10.1007","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0728-3125","authenticated-orcid":false,"given":"Takashi","family":"Satoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayato","family":"Takiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruki","family":"Uojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chisato","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiko","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohisa","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chika","family":"Kusano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Kuwana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryouichi","family":"Horie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,13]]},"reference":[{"key":"4973_CR1","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.jhep.2011.06.008","volume":"55","author":"F Violi","year":"2011","unstructured":"Violi F, Basili S, Raparelli V, Chowdary P, Gatt A, Burroughs AK (2011) Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction? J Hepatol 55:1415\u20131427. https:\/\/doi.org\/10.1016\/j.jhep.2011.06.008","journal-title":"J Hepatol"},{"key":"4973_CR2","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/liv.13317","volume":"37","author":"M Peck-Radosavljevic","year":"2017","unstructured":"Peck-Radosavljevic M (2017) Thrombocytopenia in chronic liver disease. Liver Int 37:778\u2013793. https:\/\/doi.org\/10.1111\/liv.13317","journal-title":"Liver Int"},{"key":"4973_CR3","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1007\/s10620-019-05615-5","volume":"64","author":"S Saab","year":"2019","unstructured":"Saab S, Brown RS Jr (2019) Management of thrombocytopenia in patients with chronic liver disease. Dig Dis Sci 64:2757\u20132768. https:\/\/doi.org\/10.1007\/s10620-019-05615-5","journal-title":"Dig Dis Sci"},{"key":"4973_CR4","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1053\/jhep.2003.50209","volume":"37","author":"M Kajihara","year":"2003","unstructured":"Kajihara M, Kato S, Okazaki Y, Kawakami Y, Ishii H, Ikeda Y, Kuwana M (2003) A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis. Hepatology 37:1267\u20131276. https:\/\/doi.org\/10.1053\/jhep.2003.50209","journal-title":"Hepatology"},{"key":"4973_CR5","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1159\/000510692","volume":"39","author":"N Wada","year":"2021","unstructured":"Wada N, Uojima H, Satoh T, Okina S, Iwasaki S, Shao X, Takiguchi H, Arase Y, Itokawa N, Atsukawa M, Miyazaki K, Hidaka H, Kako M, Kagawa T, Iwakiri K, Horie R, Suzuki T, Koizumi W (2021) Impact of Anti-GPIIb\/IIIa antibody-producing B cells as a predictor of the response to lusutrombopag in thrombocytopenic patients with liver disease. Dig Dis 39:234\u2013242. https:\/\/doi.org\/10.1159\/000510692","journal-title":"Dig Dis"},{"key":"4973_CR6","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1172\/JCI4238","volume":"102","author":"M Kuwana","year":"1998","unstructured":"Kuwana M, Kaburaki J, Ikeda Y (1998) Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody. J Clin Invest 102:1393\u20131402. https:\/\/doi.org\/10.1172\/JCI4238","journal-title":"J Clin Invest"},{"key":"4973_CR7","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.hoc.2013.03.001","volume":"27","author":"G Kistangari","year":"2013","unstructured":"Kistangari G, McCrae KR (2013) Immune thrombocytopenia. Hematol Oncol Clin North Am 27:495\u2013520. https:\/\/doi.org\/10.1016\/j.hoc.2013.03.001","journal-title":"Hematol Oncol Clin North Am"},{"key":"4973_CR8","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10875-009-9303-y","volume":"29","author":"XJ Zhu","year":"2009","unstructured":"Zhu XJ, Shi Y, Sun JZ, Shan NN, Peng J, Guo CS, Qin P, Hou M (2009) High-dose dexamethasone inhibits BAFF expression in patients with immune thrombocytopenia. J Clin Immunol 29:603\u2013610. https:\/\/doi.org\/10.1007\/s10875-009-9303-y","journal-title":"J Clin Immunol"},{"key":"4973_CR9","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/jth.13246","volume":"14","author":"YN Min","year":"2016","unstructured":"Min YN, Wang CY, Li XX, Hou Y, Qiu JH, Ma J, Shao LL, Zhang X, Wang YW, Peng J, Hou M, Shi Y (2016) Participation of B-cell-activating factor receptors in the pathogenesis of immune thrombocytopenia. J Thromb Haemost 14:559\u2013571. https:\/\/doi.org\/10.1111\/jth.13246","journal-title":"J Thromb Haemost"},{"key":"4973_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.clim.2017.12.010","volume":"188","author":"J Kamhieh-Milz","year":"2018","unstructured":"Kamhieh-Milz J, Ghosoun N, Sterzer V, Salama A (2018) Effect of glucocorticoid treatment on BAFF and APRIL expression in patients with immune thrombocytopenia (ITP). Clin Immunol 188:74\u201380. https:\/\/doi.org\/10.1016\/j.clim.2017.12.010","journal-title":"Clin Immunol"},{"key":"4973_CR11","doi-asserted-by":"publisher","unstructured":"Hao YF, Bi H, Li HY, Yin LM, Yu JX, Tao W, Mu HL, Yang RC, Zhou ZP, Tai WL (2021) Aberrant expression of a proliferation-inducing ligand underlies autoimmune mechanisms in immune thrombocytopenia. J Immunol Res 3676942 https:\/\/doi.org\/10.1155\/2021\/3676942","DOI":"10.1155\/2021\/3676942"},{"key":"4973_CR12","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1053\/j.seminhematol.2013.03.018","volume":"50","author":"T Nishimoto","year":"2013","unstructured":"Nishimoto T, Kuwana M (2013) CD4+CD25+FoxP3+ regulatory T cells in the pathophysiology of immune thrombocytopenia. Semin Hematol 50:S43-49. https:\/\/doi.org\/10.1053\/j.seminhematol.2013.03.018","journal-title":"Semin Hematol"},{"key":"4973_CR13","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/s0002-9343(02)01522-x","volume":"114","author":"M Kuwana","year":"2003","unstructured":"Kuwana M, Okazaki Y, Kaburaki J, Ikeda Y (2003) Detection of circulating B cells secreting platelet-specific autoantibody is useful in the diagnosis of autoimmune thrombocytopenia. Am J Med 114:322\u2013325. https:\/\/doi.org\/10.1016\/s0002-9343(02)01522-x","journal-title":"Am J Med"},{"key":"4973_CR14","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/j.1365-2141.2004.04843.x","volume":"124","author":"T Satoh","year":"2004","unstructured":"Satoh T, Pandey JP, Okazaki Y, Yasuoka H, Kawakami Y, Ikeda Y, Kuwana M (2004) Single nucleotide polymorphisms of the inflammatory cytokine genes in adults with chronic immune thrombocytopenic purpura. Br J Haematol 124:796\u2013801. https:\/\/doi.org\/10.1111\/j.1365-2141.2004.04843.x","journal-title":"Br J Haematol"},{"key":"4973_CR15","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.amjmed.2004.12.027","volume":"118","author":"M Kuwana","year":"2005","unstructured":"Kuwana M, Okazaki Y, Satoh T, Asahi A, Kajihara M, Ikeda Y (2005) Initial laboratory findings useful for predicting the diagnosis of idiopathic thrombocytopenic purpura. Am J Med 118:1026\u20131033. https:\/\/doi.org\/10.1016\/j.amjmed.2004.12.027","journal-title":"Am J Med"},{"key":"4973_CR16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/cei.12703","volume":"183","author":"K Szab\u00f3","year":"2016","unstructured":"Szab\u00f3 K, Papp G, Sz\u00e1nt\u00f3 A, Tarr T, Zeher M (2016) A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sj\u00f6gren\u2019s syndrome and systemic lupus erythematosus. Clin Exp Immunol 183:76\u201389. https:\/\/doi.org\/10.1111\/cei.12703","journal-title":"Clin Exp Immunol"},{"key":"4973_CR17","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3390\/ijms19020589","volume":"19","author":"L Alvarez-Rodriguez","year":"2018","unstructured":"Alvarez-Rodriguez L, Riancho-Zarrabeitia L, Calvo-Al\u00e9n J, L\u00f3pez-Hoyos M, Mart\u00ednez-Taboada V (2018) Peripheral B-cell subset distribution in primary antiphospholipid syndrome. Int J Mol Sci 19:589. https:\/\/doi.org\/10.3390\/ijms19020589","journal-title":"Int J Mol Sci"},{"key":"4973_CR18","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.autrev.2011.05.004","volume":"10","author":"M Miyara","year":"2011","unstructured":"Miyara M, Gorochov G, Ehrenstein M, Musset L, Sakaguchi S, Amoura Z (2011) Human FoxP3+ regulatory T cells in systemic autoimmune diseases. Autoimmun Rev 10:744\u2013755. https:\/\/doi.org\/10.1016\/j.autrev.2011.05.004","journal-title":"Autoimmun Rev"},{"key":"4973_CR19","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1080\/09537104.2020.1820975","volume":"32","author":"CE Huang","year":"2021","unstructured":"Huang CE, Chen WM, Wu YY, Shen CH, Hsu CC, Li CP, Chen MC, Chang JJ, Chen YY, Lu CH, Shi CS, Chen CC (2021) Comparison of antiplatelet antibody profiles between hepatitis C virus-associated immune thrombocytopenia and primary immune thrombocytopenia. Platelets 32:1043\u20131050. https:\/\/doi.org\/10.1080\/09537104.2020.1820975","journal-title":"Platelets"},{"key":"4973_CR20","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1182\/blood-2008-09-181073","volume":"113","author":"W Zhang","year":"2009","unstructured":"Zhang W, Nardi MA, Borkowsky W, Li Z, Karpatkin S (2009) Role of molecular mimicry of hepatitis C virus protein with platelet GPIIIa in hepatitis C-related immunologic thrombocytopenia. Blood 113:4086\u20134093. https:\/\/doi.org\/10.1182\/blood-2008-09-181073","journal-title":"Blood"},{"key":"4973_CR21","doi-asserted-by":"crossref","unstructured":"Satoh T, Kuwana M (2017) Differential Diagnosis: Secondary ITP. In: Ishida Y, Tomiyama Y, editors. Autoimmune thrombocytopenia. Singapore, Springer Nature; p. 97\u2013105.","DOI":"10.1007\/978-981-10-4142-6_9"},{"key":"4973_CR22","doi-asserted-by":"publisher","first-page":"e86943","DOI":"10.1371\/journal.pone.0086943","volume":"9","author":"M Kuwana","year":"2014","unstructured":"Kuwana M, Okazaki Y, Ikeda Y (2014) Detection of circulating B cells producing anti-GPIb autoantibodies in patients with immune thrombocytopenia. PLoS ONE 9:e86943. https:\/\/doi.org\/10.1371\/journal.pone.0086943","journal-title":"PLoS ONE"},{"key":"4973_CR23","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nri844","volume":"2","author":"F Mackay","year":"2002","unstructured":"Mackay F, Browning JL (2002) BAFF: a fundamental survival factor for B cells. Nat Rev Immunol 2:465\u2013475. https:\/\/doi.org\/10.1038\/nri844","journal-title":"Nat Rev Immunol"},{"key":"4973_CR24","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1212\/01.wnl.0000313840.27060.bf","volume":"70","author":"MC Dalakas","year":"2008","unstructured":"Dalakas MC (2008) Invited Article: inhibition of B cell functions: implications for neurology. Neurology 70:2252\u20132260. https:\/\/doi.org\/10.1212\/01.wnl.0000313840.27060.bf","journal-title":"Neurology"},{"key":"4973_CR25","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.clim.2012.11.010","volume":"148","author":"A La Cava","year":"2013","unstructured":"La Cava A (2013) Targeting the BLyS-APRIL signaling pathway in SLE. Clin Immunol 148:322\u2013327. https:\/\/doi.org\/10.1016\/j.clim.2012.11.010","journal-title":"Clin Immunol"},{"key":"4973_CR26","doi-asserted-by":"publisher","first-page":"5362","DOI":"10.1182\/blood-2009-05-217513","volume":"114","author":"XJ Zhu","year":"2009","unstructured":"Zhu XJ, Shi Y, Peng J, Guo CS, Shan NN, Qin P, Ji XB, Hou M (2009) The effects of BAFF and BAFF-R-Fc fusion protein in immune thrombocytopenia. Blood 114:5362\u20135367. https:\/\/doi.org\/10.1182\/blood-2009-05-217513","journal-title":"Blood"},{"key":"4973_CR27","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1111\/jgh.14123","volume":"33","author":"H Doi","year":"2018","unstructured":"Doi H, Hayashi E, Arai J, Tojo M, Morikawa K, Eguchi J, Ito T, Kanto T, Kaplan DE, Yoshida H (2018) Enhanced B-cell differentiation driven by advanced cirrhosis resulting in hyperglobulinemia. J Gastroenterol Hepatol 33:1667\u20131676. https:\/\/doi.org\/10.1111\/jgh.14123","journal-title":"J Gastroenterol Hepatol"},{"key":"4973_CR28","doi-asserted-by":"publisher","first-page":"11522","DOI":"10.3748\/wjg.v21.i41.11522","volume":"21","author":"M Mart\u00ednez-Esparza","year":"2015","unstructured":"Mart\u00ednez-Esparza M, Trist\u00e1n-Manzano M, Ruiz-Alcaraz AJ, Garc\u00eda-Pe\u00f1arrubia P (2015) Inflammatory status in human hepatic cirrhosis. World J Gastroenterol 21:11522\u201311541. https:\/\/doi.org\/10.3748\/wjg.v21.i41.11522","journal-title":"World J Gastroenterol"},{"key":"4973_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-021-07378-4","author":"AJ Czaja","year":"2022","unstructured":"Czaja AJ (2022) Advancing biologic therapy for refractory autoimmune hepatitis. Dig Dis Sci. https:\/\/doi.org\/10.1007\/s10620-021-07378-4","journal-title":"Dig Dis Sci"},{"key":"4973_CR30","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1002\/art.34400","volume":"64","author":"W Stohl","year":"2012","unstructured":"Stohl W, Hiepe F, Latinis KM, Thomas M, Scheinberg MA, Clarke A, Aranow C, Wellborne FR, Abud-Mendoza C, Hough DR, Pineda L, Migone TS, Zhong ZJ, Freimuth WW, Chatham WW (2012) Belimumab reduces autoantibody, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus. Arthritis Rheum 64:2328\u20132337. https:\/\/doi.org\/10.1002\/art.34400","journal-title":"Arthritis Rheum"},{"key":"4973_CR31","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1093\/rheumatology\/kev005","volume":"54","author":"E Pontarini","year":"2015","unstructured":"Pontarini E, Fabris M, Quartuccio L, Cappeletti M, Calcaterra F, Roberto A, Curcio F, Mavilio D, Della Bella S, De Vita S (2015) Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren\u2019s syndrome. Rheumatology 54:1429\u20131434. https:\/\/doi.org\/10.1093\/rheumatology\/kev005","journal-title":"Rheumatology"},{"key":"4973_CR32","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.coi.2008.09.001","volume":"20","author":"E Meffre","year":"2008","unstructured":"Meffre E, Wardemann H (2008) B-cell tolerance checkpoints in health and autoimmunity. Curr Opin Immunol 20:632\u2013638. https:\/\/doi.org\/10.1016\/j.coi.2008.09.001","journal-title":"Curr Opin Immunol"},{"key":"4973_CR33","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1046\/j.1365-2141.2003.04509.x","volume":"122","author":"H Chan","year":"2003","unstructured":"Chan H, Moore JC, Finch CN, Warkentin TE, Kelton JG (2003) The IgG subclasses of platelet-associated autoantibodies directed against platelet glycoproteins IIb\/IIIa in patients with idiopathic thrombocytopenic purpura. Br J Haematol 122:818\u2013824. https:\/\/doi.org\/10.1046\/j.1365-2141.2003.04509.x","journal-title":"Br J Haematol"},{"key":"4973_CR34","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.4049\/jimmunol.168.7.3675","volume":"168","author":"M Kuwana","year":"2002","unstructured":"Kuwana M, Okazaki Y, Kaburaki J, Kawakami Y, Ikeda Y (2002) Spleen is a primary site for activation of platelet-reactive T and B cells in patients with immune thrombocytopenic purpura. J Immunol 168:3675\u20133682. https:\/\/doi.org\/10.4049\/jimmunol.168.7.3675","journal-title":"J Immunol"},{"key":"4973_CR35","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/ajh.20951","volume":"82","author":"M Kuwana","year":"2007","unstructured":"Kuwana M, Iki S, Urabe A (2007) The role of autoantibody-producing plasma cells in immune thrombocytopenic purpura refractory to rituximab. Am J Hematol 82:846\u2013848. https:\/\/doi.org\/10.1002\/ajh.20951","journal-title":"Am J Hematol"},{"key":"4973_CR36","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/s1521-6616(03)00092-5","volume":"108","author":"Y Shi","year":"2003","unstructured":"Shi Y, Agematsu K, Ochs HD, Sugane K (2003) Functional analysis of human memory B-cell subpopulations: IgD+CD27+ B cells are crucial in secondary immune response by producing high affinity IgM. Clin Immunol 108:128\u2013137. https:\/\/doi.org\/10.1016\/s1521-6616(03)00092-5","journal-title":"Clin Immunol"},{"key":"4973_CR37","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1126\/science.1076071","volume":"298","author":"NL Bernasconi","year":"2002","unstructured":"Bernasconi NL, Traggiai E, Lanzavecchia A (2002) Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298:2199\u20132202. https:\/\/doi.org\/10.1126\/science.1076071","journal-title":"Science"},{"key":"4973_CR38","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1538-7836.2008.03161.x","volume":"7","author":"M Kuwana","year":"2009","unstructured":"Kuwana M, Okazaki Y, Ikeda Y (2009) Splenic macrophages maintain the anti-platelet autoimmune response via uptake of opsonized platelets in patients with immune thrombocytopenic purpura. J Thromb Haemost 7:322\u2013329. https:\/\/doi.org\/10.1111\/j.1538-7836.2008.03161.x","journal-title":"J Thromb Haemost"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04973-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-022-04973-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04973-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T05:05:55Z","timestamp":1665119155000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-022-04973-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,13]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["4973"],"URL":"https:\/\/doi.org\/10.1007\/s00277-022-04973-x","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,13]]},"assertion":[{"value":"7 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study design was approved by the Institutional Review Boards at Kitasato University (B18-095). All subjects were in accordance with the Helsinki Declaration of 1975, as revised in 2008.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}